Background: Cerebral oxygenation monitoring utilising near-infrared spectroscopy (NIRS) is increasingly used to guide interventions in clinical care. The objective of this systematic review with meta-analysis and Trial Sequential Analysis is to evaluate the effects of clinical care with access to cerebral NIRS monitoring in children and adults versus care without. Methods: This review conforms to PRISMA guidelines and was registered in PROSPERO (CRD42020202986). Methods are outlined in our protocol (doi: 10.1186/s13643-021-01660-2). Results: Twenty-five randomised clinical trials were included (2606 participants). All trials were at a high risk of bias. Two trials assessed the effects of NIRS during neonatal intensive care, 13 during cardiac surgery, 9 during non-cardiac surgery and 1 during neurocritical care. Meta-analyses showed no significant difference for all-cause mortality (RR 0.75, 95% CI 0.51–1.10; 1489 participants; I2 = 0; 11 trials; very low certainty of evidence); moderate or severe, persistent cognitive or neurological deficit (RR 0.74, 95% CI 0.42–1.32; 1135 participants; I2 = 39.6; 9 trials; very low certainty of evidence); and serious adverse events (RR 0.82; 95% CI 0.67–1.01; 2132 participants; I2 = 68.4; 17 trials; very low certainty of evidence). Conclusion: The evidence on the effects of clinical care with access to cerebral NIRS monitoring is very uncertain. Impact: The evidence of the effects of cerebral NIRS versus no NIRS monitoring are very uncertain for mortality, neuroprotection, and serious adverse events. Additional trials to obtain sufficient information size, focusing on lowering bias risk, are required.The first attempt to systematically review randomised clinical trials with meta-analysis to evaluate the effects of cerebral NIRS monitoring by pooling data across various clinical settings.Despite pooling data across clinical settings, study interpretation was not substantially impacted by heterogeneity.We have insufficient evidence to support or reject the clinical use of cerebral NIRS monitoring.

Cerebral near-infrared spectroscopy monitoring (NIRS) in children and adults: a systematic review with meta-analysis / Hansen M.L.; Hyttel-Sorensen S.; Jakobsen J.C.; Gluud C.; Kooi E.M.W.; Mintzer J.; de Boode W.P.; Fumagalli M.; Alarcon A.; Alderliesten T.; Greisen G.; Austin T.; Bruckner M.; de Boode W.P.; Dempsey E.; Ergenekon E.; Gucuyener K.; Levy P.T.; Liem K.D.; Martini S.; Naulaers G.; Neunhoeffer F.; Pellicer A.; Pichler G.; Roehr C.C.; Roll C.; Schwarz C.E.; Szczapa T.; Urlesberger B.; Wolf M.; Wong F.; Rhee C.J.; Lemmers P.. - In: PEDIATRIC RESEARCH. - ISSN 0031-3998. - ELETTRONICO. - -:-(2022), pp. 1-12. [10.1038/s41390-022-01995-z]

Cerebral near-infrared spectroscopy monitoring (NIRS) in children and adults: a systematic review with meta-analysis

Martini S.;
2022

Abstract

Background: Cerebral oxygenation monitoring utilising near-infrared spectroscopy (NIRS) is increasingly used to guide interventions in clinical care. The objective of this systematic review with meta-analysis and Trial Sequential Analysis is to evaluate the effects of clinical care with access to cerebral NIRS monitoring in children and adults versus care without. Methods: This review conforms to PRISMA guidelines and was registered in PROSPERO (CRD42020202986). Methods are outlined in our protocol (doi: 10.1186/s13643-021-01660-2). Results: Twenty-five randomised clinical trials were included (2606 participants). All trials were at a high risk of bias. Two trials assessed the effects of NIRS during neonatal intensive care, 13 during cardiac surgery, 9 during non-cardiac surgery and 1 during neurocritical care. Meta-analyses showed no significant difference for all-cause mortality (RR 0.75, 95% CI 0.51–1.10; 1489 participants; I2 = 0; 11 trials; very low certainty of evidence); moderate or severe, persistent cognitive or neurological deficit (RR 0.74, 95% CI 0.42–1.32; 1135 participants; I2 = 39.6; 9 trials; very low certainty of evidence); and serious adverse events (RR 0.82; 95% CI 0.67–1.01; 2132 participants; I2 = 68.4; 17 trials; very low certainty of evidence). Conclusion: The evidence on the effects of clinical care with access to cerebral NIRS monitoring is very uncertain. Impact: The evidence of the effects of cerebral NIRS versus no NIRS monitoring are very uncertain for mortality, neuroprotection, and serious adverse events. Additional trials to obtain sufficient information size, focusing on lowering bias risk, are required.The first attempt to systematically review randomised clinical trials with meta-analysis to evaluate the effects of cerebral NIRS monitoring by pooling data across various clinical settings.Despite pooling data across clinical settings, study interpretation was not substantially impacted by heterogeneity.We have insufficient evidence to support or reject the clinical use of cerebral NIRS monitoring.
2022
Cerebral near-infrared spectroscopy monitoring (NIRS) in children and adults: a systematic review with meta-analysis / Hansen M.L.; Hyttel-Sorensen S.; Jakobsen J.C.; Gluud C.; Kooi E.M.W.; Mintzer J.; de Boode W.P.; Fumagalli M.; Alarcon A.; Alderliesten T.; Greisen G.; Austin T.; Bruckner M.; de Boode W.P.; Dempsey E.; Ergenekon E.; Gucuyener K.; Levy P.T.; Liem K.D.; Martini S.; Naulaers G.; Neunhoeffer F.; Pellicer A.; Pichler G.; Roehr C.C.; Roll C.; Schwarz C.E.; Szczapa T.; Urlesberger B.; Wolf M.; Wong F.; Rhee C.J.; Lemmers P.. - In: PEDIATRIC RESEARCH. - ISSN 0031-3998. - ELETTRONICO. - -:-(2022), pp. 1-12. [10.1038/s41390-022-01995-z]
Hansen M.L.; Hyttel-Sorensen S.; Jakobsen J.C.; Gluud C.; Kooi E.M.W.; Mintzer J.; de Boode W.P.; Fumagalli M.; Alarcon A.; Alderliesten T.; Greisen G.; Austin T.; Bruckner M.; de Boode W.P.; Dempsey E.; Ergenekon E.; Gucuyener K.; Levy P.T.; Liem K.D.; Martini S.; Naulaers G.; Neunhoeffer F.; Pellicer A.; Pichler G.; Roehr C.C.; Roll C.; Schwarz C.E.; Szczapa T.; Urlesberger B.; Wolf M.; Wong F.; Rhee C.J.; Lemmers P.
File in questo prodotto:
File Dimensione Formato  
2022 Ped Res_a.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.4 MB
Formato Adobe PDF
1.4 MB Adobe PDF Visualizza/Apri
41390_2022_1995_MOESM1_ESM.pdf

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 7.07 MB
Formato Adobe PDF
7.07 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/968935
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 21
social impact